课题基金 / 基金详情

Genetic Control of Nutrition Starvation in Yeast

Genetic Control of Nutrition Starvation in Yeast
酵母营养饥饿的遗传控制
批准号:
7152506
负责人:
GERALD R FINK
金额:
$62.94万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-07-01 至 2008-11-30

项目摘要

项目成果

GERALD R FINK的其他基金

相似基金

相关文献

中文摘要
翻译
这项建议将利用酿酒酵母和白色念珠菌的分子遗传学来确定多倍体和基因复制在基因表达中的作用。基因组是通过复制现有的遗传物质而进化的,无论是整个基因组还是单个基因;然而,这种复制可能会导致异常生长。许多肿瘤含有很大比例的超倍体细胞,对于一些肿瘤来说,倍体增加预示着对抗有丝分裂药物的敏感性增加,预后良好。实验旨在利用全基因组敲除文库鉴定多倍体形成和多倍体细胞在稳定期生存所需的所有酵母菌基因。基因沉默在控制多倍体GONE表达中的作用将通过全基因组染色质免疫沉淀来确定。Flo基因是一个高度复制的Gone家族,有一个表达位点(Fl011),以及许多沉默的亚端粒成员,其基因沉默和变异的机制将被阐明。这些实验将确定染色质因子、营养、突变和重组在沉默和去沉默全套Flo基因中的作用。实验还被设计用来揭示非端粒基因FL011在表观遗传上在“开”和“关”状态之间切换的机制。全基因组筛查将识别基因表达中的多样性的流行程度。由于Flo基因是真菌的细胞表面粘附素,它们的转换能力可能是病原菌的关键毒力因子。沉默和去沉默对人类健康的重要性将在人类真菌病原体白色念珠菌中确定,白色念珠菌是一种专性二倍体。念珠菌对抗真菌药物氟康唑的耐药性在隐性erg3突变杂合子菌株中是不稳定的。我们将确定二倍体和组蛋白去乙酰基酶在产生高水平耐药中的作用,并将通过这种沉默机制筛选念珠菌基因组中导致氟康唑耐药的其他基因。这些假丝酵母菌研究可以确定将提高当前抗真菌疗法有效性的因素。使用DNA微阵列的实验旨在识别酵母菌用来检测其密度的化合物。拟议的实验将使人们更深入地了解在低细胞密度下增殖的能力,这对真菌病原体来说是一个更现实的情景。
英文摘要
This proposal will use the molecular genetics of Saccharomyces cerevisiae and Candida albicans to determine the role of polyploidy and gene duplications in gene expression. Genomes have evolved by duplication of existing genetic material, either whole genomes or individual genes; however, such duplications can lead to abnormal growth. Many tumors contain a large proportion of cells that are hyperploid, and, for some, increased ploidy carries a good prognosis, predicting an increased sensitivity to anti-mitotic drugs. Experiments are designed to identify all the Saccharomyces genes required for polyploid formation and for the survival of polyploid cells in stationary phase using whole genome knockout libraries. The role of gene silencing in the control of gone expression in polyploids will be determined by whole genome chromatin immunoprecipitation. The mechanism of gene silencing and variegation will be elucidated for the FLO genes, a highly duplicated gone family with one expressed locus (FL011), and many silent subtelomeric members. These experiments will determine the role of chromatin factors, nutrition, mutation, and recombination in silencing and desilencing the ensemble of FLO genes. Experiments are also designed to reveal the mechanism by which the non-telomeric gene FL011 switches epigenetically between the "on" and "off" states. A genome wide screen will identify the prevalence of variegation in gene expression. As FLO genes are the cell surface adhesins of fungi, their ability to switch could be critical virulence factors in pathogens. The importance of silencing and desilencing for human health will be determined in the human fungal pathogen, Candida albicans, an obligate diploid. Candida's resistance to the antifungal agent, fluconazole, is unstable in strains heterozygous for the recessive erg3 mutation. We will determine the role of diploidy and the histone deactylases in generating high-level drug resistance and will screen the Candida genome for other genes that lead to fluconazole resistance by this silencing mechanism. These Candida studies could identify the factors that will improve the effectiveness of current antifungal therapies. Experiments using DNA microarrays are designed to identify compounds used by Saccharomyces to sense its density. The experiments proposed will lead to a deeper understanding of the ability to proliferate at low cell densities, a more realistic scenario for fungal pathogens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR BIOLOGY OF INFECTIONS DISEASE
BIOMEDICAL RESEARCH SUPPORT GRANT
BIOLOGICAL FUSIONS--CONJUGATION IN YEAST
GENETIC CONTROL OF NUTRITIONAL STARVATION IN YEAST
海外基金